NCT06788938: An ongoing trial by Jonsson Comprehensive Cancer Center
This trial is ongoing. It must report results 3 years, 4 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06788938 |
|---|---|
| Title | Tarlatamab in Advanced DLL3-Expressing Tumors Including Neuroendocrine Neoplasms |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 21, 2025 |
| Completion date | April 24, 2028 |
| Required reporting date | April 24, 2029, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |